|
시장보고서
상품코드
2075225
피하 약물전달 시장 : 편의성별, 질환 적응별, 전달 시스템별, 유통 채널별 및 지역별Subcutaneous Drug Delivery Market, By Usability, By Disease Indication, By Delivery SystemBy Distribution Channel, and By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
피하 약물전달 시장 규모는 2026년에 157억 달러로 추계되고 있으며, 2033년까지 304억 1,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 9.9%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 157억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.90% | 2033년 시장 규모 예측 : | 304억 1,000만 달러 |
프리필드 주사기 및 자동 주사기의 기술 혁신과 개발이 시장 성장에 기여하고 있습니다. 예를 들어 독일의 1차 포장 제조업체인 게레스하이머사는 2020년 6월에 금속을 포함하지 않는 ‘Lure Lock Gx RTF 주사기'를 발매했습니다. 이 제품은 텅스텐을 사용하지 않으며, 생명공학 기술을 통해 제조된 유효 성분에 대해 금속으로 인한 오염 가능성을 이상적으로 배제하는 최적의 1차 포장재입니다.
또한 2022년 3월에는 의료기기 제조사인 입소메드(YpsoMed)가 자체 개발한 ‘YpsoMate' 펜에 장착하는 재사용 가능한 어태치먼트 'YpsoMate SmartPilot'를 개발했습니다. 이는 2단계의 간단한 주사 과정을 가능하게 하도록 설계되었습니다. 이 기기에는 센서와 메모리가 탑재되어 있으며, 앱과 연동하여 주사 시기와 투여량을 표시합니다. 또한 이 펜은 사용자에게 음성 및 시각적 피드백을 제공합니다. 또한 이 앱은 사용자에게 인슐린 주사 시간을 알려줄 수도 있습니다.
시장 역학
예측 기간 중 규제 당국의 제품 승인이 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 2023년 3월 6일, 세계적인 바이오시밀러 기업인 Coherus BioSciences, Inc.는 미국 식품의약국(FDA)이 UDENYCA(페그필글라스팀-cbqv)의 1회 투여용 프리필드 자동 주사기 제형을 승인했다고 발표했습니다. UDENYCA의 자동 주사기는 진료소와 가정에서의 치료 모두에서 사용할 수 있도록 간단하고 사용하기 편리한 디자인으로 제작되었습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수(기업 개요, 재무 실적, 제품 포트폴리오, 시장내 입지, 유통 전략, 주요 발전, 전략 및 향후 계획)를 바탕으로 전 세계 피하 투여 의약품 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻을 수 있는 인사이트는 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내릴 수 있도록 해줍니다.
- 세계의 피하 약물전달 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 피하 약물전달 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계에서 피하 약물전달
제5장 세계의 피하 약물전달 시장 : 편의성별, 2021-2033년
제6장 세계의 피하 약물전달 시장 : 질환 적응증별, 2021-2033년
제7장 세계의 피하 약물전달 시장 : 투여 시스템별, 2021-2033년
제8장 세계의 피하 약물전달 시장 : 유통 채널별, 2021-2033년
제9장 세계의 피하 약물전달 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.07Subcutaneous Drug Delivery Market is estimated to be valued at USD 15.70 Bn in 2026 and is expected to reach USD 30.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 15.70 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.90% | 2033 Value Projection: | USD 30.41 Bn |
Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.
Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.
Market Dynamics
Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global subcutaneous drug delivery market based on the following parameters-company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
- Global Subcutaneous Drug Delivery Market, Usability
- Disposable
- Reusable
- Global Subcutaneous Drug Delivery Market, Disease Indication
- Auto-immune Disorders
- Neurological Disorders
- Oncology Disorders
- Hormonal Disorders
- Allergy & Infectious Disorders
- Ophthalmic Disorders
- Others
- Global Subcutaneous Drug Delivery Market, Delivery System
- Prefilled Syringes
- Autoinjector
- Spring Type
- Motorized Type
- Wearable Type
- Pen Injectors
- Disposable
- Reusable
- Syringes (Injector)
- Others (pump, etc.)
- Global Subcutaneous Drug Delivery Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Subcutaneous Drug Delivery Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Country:
- U.S.
- Canada
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country:
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country:
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country:
- GCC Countries
- Israel
- Rest of Middle East
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Country/Region:
- Company Profiles
- Becton Dickinson and Company,
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novo Nordisk A/S,
- Johnson & Johnson
- Novartis International AG
- Amgen, Inc.
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.,
- Consort Medical plc,
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation,
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Usability
- Market Snapshot, By Disease Indication
- Market Snapshot, By Delivery System
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Merger, Acquisition, and Collaborations
- Product Launch
- Regulatory Scenario
- PEST Analysis
4. Global Subcutaneous Drug Delivery
- Economic Impact
- Impact on Supply and Demand
5. Global Subcutaneous Drug Delivery Market, By Usability, 2021€"2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Auto-immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Oncology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Hormonal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Allergy & Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Ophthalmic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Auto injector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Pen Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Others (pump, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
9. Global Subcutaneous Drug Delivery Market, By Region, 2021€"2033, (US$ Billion)
- Overview
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022€"2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Becton Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk A/S
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Amgen, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche AG.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Consort Medical plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- LaVision Biotec GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Insulet Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- West Pharmaceutical Services, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Gerresheimer AG.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Becton Dickinson and Company
11. Section
- References
- Research Methodology
- About us and Sales Contact
